Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Safe and successful treatment with erlotinib after gefitinib-induced hepatotoxicity: difference in metabolism as a possible mechanism.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Jul 2011

Kijima Takashi, Shimizu Tomohito, Nonen Shinpei, Furukawa Mitsugi, Otani Yasushi, Minami Toshiyuki, Takahashi Ryo, Hirata Haruhiko, Nagatomo Izumi, Takeda Yoshito, Kida Hiroshi, Goya Sho, Fujio Yasushi, Azuma Junichi, Tachibana Isao, Kawase Ichiro

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Chemical and Drug Induced Liver Injury
Share to Erlotinib Hydrochloride

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gefitinib

Share to Quinazolines

Share to Transaminases

Source

Identifiers

PMID: 21502555
DOI: 10.1200/JCO.2010.34.3368

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Safe and successful treatment with erlotinib after gefitinib-induced hepatotoxicity: difference in metabolism as a possible mechanism.PMID 21502555Read ↗

Drug-induced effects on erlotinib metabolism.Semantic proximity Read ↗

Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines.Semantic proximity Read ↗

Current Concepts of Mechanisms in Drug-Induced HepatotoxicitySemantic proximity Read ↗

[Efficacy of low-dose erlotinib against gefitinib-induced hepatotoxicity in a patient with lung adenocarcinoma harboring EGFR mutations].Semantic proximity Read ↗

The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury.Semantic proximity Read ↗

Mechanisms of Drug-induced Liver InjurySemantic proximity Read ↗

Impaired Liver Function Implied Shorter Progression Free Survival for EGFR Tyrosine Kinase InhibitorsSemantic proximity Read ↗

Potential influence of being overweight on the development of hepatic dysfunction in Japanese patients with EGFR-mutated non-small cell lung cancer undergoing gefitinib monotherapy: the Okayama Lung Cancer Study Group experience.Semantic proximity Read ↗

Mechanisms of Drug-Induced Liver DiseaseSemantic proximity Read ↗

Safe and successful treatment with afatinib in three postoperative non-small cell lung cancer patients with recurrences following gefitinib/erlotinib-induced hepatotoxicity.Semantic proximity Read ↗

Severe hepatotoxicity during treatment with capmatinib.Semantic proximity Read ↗

Drug-induced liver injury in older people.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.